Online Publications

  • Castillo D, Pairawan S, Denham L, Lum SS, Nagaraj G. Biomarker Evolution after Neoadjuvant systemic therapy in Breast Cancer. (06/2022) (link)
  • Moyers, J; Chong, E; Nagaraj, G. Treatment outcomes in melanoma with brain metastases in the era of immunotherapy: An analysis of the National Cancer Database.” ASCO 2020 e-abstract e19029 (2020)
  • Salman O, Dwivedi A, Nguyen. A, Alvarado A, Nagaraj G.  Prognostic impact of age at diagnosis in triple negative breast cancer: Analysis of 204 patients from single institution registry. ASCO Annual Meeting 2018. E publication: e13130 (2018)
  • Oregel KZ, Ratanatharathorn C and Nagaraj G. Paraneoplastic Pemphigus in Setting of Waldenstrom’s Macroglobulinemia. Austin J Clin Pathol. 2016; 3(1): 1039. (2016)
  • Nagaraj G, Pacheco J, Ellis MJ, Margenthaler JA, Ma CX. Management of premenopausal women with neoadjuvant endocrine therapy: A single institution experience. ASCO Annual Meeting. J Clin Oncol 29, 2011 (Suppl; abstract No: e11014). (2011)

Scholarly Journals--Published

  • Rubinstein SM, Bhutani D, Lynch RC…. Nagaraj G…. Zubiri L, Warner JL, Thompson M A, COVID-19 and Cancer Consortium. Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19. Blood Cancer Discov.2022 May 5;3(3):181-193. doi: 10.1158/2643-3230.BCD-22-0013. PMID: 35262738 (05/2022)
  • Schmidt AL, Labaki C, Hsu C-Y… Nagaraj G… Shyr Yu, Warner JL, Choueiri TK, COVID-19 and Cancer Consortium. COVID-19 vaccination and breakthrough infections in patients with cancer. Ann Oncol. 2022 Mar;33(3):340-346.  doi: 10.1016/j.annonc.2021.12.006. Epub 2021 Dec 24. PMID: 34958894 (03/2022)
  • Satyanarayana G, Enriquez KT, Sun T, …Nagaraj G… Warner JL, French B, Farmakiotis D. Coinfections in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study. Open Forum Infect Dis. 2022 Feb 14;9(3): ofac037. doi: 10.1093/ofid/ofac037. eCollection 2022 Mar. PMID: 35198648 (02/2022)
  • Coffman AR, Sufficool DC, Kang JI, Hsueh CT, Swenson S, McGee PQ, Nagaraj G, Patyal B, Reeves ME, Slater J, Yang GY. Proton SBRT for Liver Metastases – Results of 5-year Experience for 81 Hepatic Lesions. J Gastrointest Oncol. 2021 Aug; 12(4): 1753–1760. doi: 10.21037/jgo-20-424. PMID: 34532125 (08/2021)
  • Grivas P, Khaki AR, Wise-Draper TM…. Nagaraj G… Shah DP, Warner LJ, Lopes GdL. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. Ann Oncol. 2021 Jun;32(6):787-800. doi: 10.1016/j.annonc.2021.02.024. Epub 2021 Mar 19. PMID: 33746047 (06/2021)
  • Moyers, J, Chong, EG, Peng J, Tsai HHC, Sufficool D, Shavlik D, Nagaraj G. Real World Outcomes of Combination and Timing of Immunotherapy with Radiotherapy for Melanoma with Brain Metastasis. Cancer Med 2021 Feb;10(4):1201-1211. doi: 10.1002/cam4.3716. Epub 2021 Jan 22. PMID: 33484100 (02/2021)
  • Chong EG, Lee EH, Sail R, Denham L, Nagaraj G, Hsueh CT. Anthracycline-induced cardiotoxicity: A case report and review of literature. World J Cardiol. 2021 Jan 26;13(1):28-37. doi: 10.4330/wjc.v13.i1.28.PMID: 33552401 (01/2021)
  • Nagaraj G. Ma CX. Clinical Challenges in the Management of Hormone Recepter-Positive, Human Epidermal Growth Factor Receptor-2 Negative Metastatic Breast Cancer: A Literature Review. Adv Ther. 2020 Nov 15. 2020 Nov 15.doi: 10.1007/s12325-020-01552-2. PMID: 33190190 (11/2020)
  • Lee EH, Otoukesh S, Abdipour A, Nagaraj G. Hemolytic anemia of malignancy: a case study involving signet ring cell metastatic breast cancer with severe microangiopathic hemolytic anemia. Case Rep Oncol. 2019 Jan 23;12(1):104-108. doi: 10.1159/000494753.  PMID: 31043946. (01/2019)
  • Nguyen AL, Kamal M, Raghavan R, Nagaraj G. Acquired factor VII Deficiency Causing Severe Bleeding Disorder Secondary to AL Amyloidosis of the Liver. Hematol Rep. 2018 Sep 24;10(3):7235. doi: 10.4081/hr.2018.7235. PMID: 30344985 (09/2018)
  • Campbell  PS, Mavingire N, Khan S, Rowland LK, Wooten JV, Opoku-Agyeman A, Guevara A, Soto U, Cavalli F, Perez AL, Nagaraj G, Denham LJ, Adeoye O, Jenkins BD, Davis MB, Schiff R  Brantley EJ.  AhR ligand Aminoflavone suppresses ?6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells. J Cell Physiol. 2018 Aug 4. doi: 10.1002/jcp.27013. PMID: 30076704 (08/2018)
  • Shaheen S, Mirshahidi H, Nagaraj G, Hsueh CT. Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature. Exp Hematol Oncol. 2018 May 8;7:11. doi: 10.1186/s40164-018-0104-y. eCollection 2018.  PMID: 29761026 (05/2018)
  • Nahleh Z, Otoukesh S, Mirshahidi HR, Nguyen AL, Nagaraj G, Botrus G, Badri N, Diab N, Alvarado A, Sanchez LA, Dwivedi AK. Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics.  Cancer Med. 2018 May 7. doi: 10.1002/cam4.1509. PMID: 29733543 (05/2018)
  • Oregel KZ, Shouse GP, Oster C, Martinez F, Wang J, Rosenzweig M, Deisch JK, Chen CS, Nagaraj G. Atypical Presentation of Gelsolin Amyloidosis in a Man of African Descent with a Novel Mutation in the Gelsolin Gene. Am J Case Rep. 2018 Mar 30;19:374-381. PMID:29599423 (03/2018)
  • Oregel KZ, Everett E, Zhang X, Nagaraj G. Complete Response in a critically ill patient with ALK-negative Anaplastic Large Cell Lymphoma treated with single agent Brentuximab-vedotin. Case report accepted to Expert Review of Anticancer Therapy. Expert Rev Anticancer Ther. 2016;16(3):279-83. doi: 10.1586/14737140.2016.1146597. PMID: 26809026 (2016)
  • Ma CX, Luo J, Naughton M, Ademuyiwa F, Suresh R, Griffith M, Griffith OL, Skidmore ZL, Spies NC, Ramu A, Trani L, Pluard T, Nagaraj G, Thomas S, Guo Z, Hoog J, Han J, Mardis E, Lockhart C, Ellis MJ. A Phase 1 trial of BKM 120 (Buparlisib) in combination with fulvestrant in postmenopausal women with estrogen receptor positive metastatic breast cancer. Clin Cancer Res. 2015 Nov 12. pii: clincanres.1745.2015. [Epub ahead of print]. PMID: 26563128. (11/2015)
  • Cho M, Wang-Gillam A, Myerson R, Gao F, Strasberg S, Picus J, Sorscher S, Fournier C, Nagaraj G, Parikh P, Suresh R, Linehan D, Tan BR. A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradiation in a resected pancreaticobiliary carcinoma. HPB (Oxford). 2015 Jul;17(7):587-93. doi: 10.1111/hpb.12413. Epub 2015 Mar 20. PMID: 25800066 (07/2015)
  • Nagaraj G, Ma CX. Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor- positive metastatic breast cancer. Breast Cancer Res Treat. 2015 Apr;150(2):231-42. doi: 10.1007/s10549-015-3316-4. Epub 2015 Mar 12. Review. PMID: 25762475 (04/2015)
  • Cho M, Wang-Gillam A, Myerson R, Gao F, Strasberg S, Picus J, Sorscher S, Fournier C, Nagaraj G, Parikh P, Suresh R, Linehan D, Tan BR. A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma. HPB: The Official Journal of the International Hepato Pacreato Biliary Association, 17(7), 587-593. (2015) (link)
  • Nagaraj G, Zarbalian Y, Flora K, Tan BR Jr. Complete response and prolonged disease-free survival in a patient with recurrent duodenal adenocarcinoma treated with bevacizumab plus FOLFOX6. J Gastrointest Oncol. 2014 Feb;5(1):E1-6. doi: 10.3978/j.issn.2078-6891.2013.038. PMID: 24490045. (02/2014)
  • Subramanian J, Regenbogen T, Nagaraj G, Lane A, Devarakonda S, Zhou G F, & Govindan R. (2013). Review of Ongoing Clinical Trials in Non-Small-Cell Lung Cancer A Status Report for 2012 from the ClinicalTrialsgov Web Site. Journal of Thoracic Oncology, 8(7), 860-865. (07/2013) (link)
  • J Subramanian, T Regenbogen, G Nagaraj, A Lane, S Devarakonda, G Zhou, R Govindan. Review of ongoing clinical trials in non-small-cell lung cancer: A status report for 2012 from the website. J Thorac Oncol. 2013 Mar 8. [Epub ahead of print]. (03/2013)
  • G Nagaraj, CX Ma. Adjuvant chemotherapy decisions in clinical practice for early-stage node-negative, estrogen receptor-positive, HER2-negative breast cancer: challenges and considerations. J Natl Compr Canc Netw 2013 Mar 1; 11(3):246-51. (03/2013)
  • G Nagaraj, MJ Ellis, CX Ma. Commentary. The natural history of hormone receptor-positive breast cancer: attempting to decipher an intriguing concept. Oncology (Williston Park). 2012 Aug;26(8):696-7, 700. (08/2012)
  • LS Bachegowda, G Nagaraj, PD Grivas, L Chen, E Choi, M Styler. Two “childhood” malignancies in an elderly woman: A case report and discussion. Med Oncol. 2010 Sep;27(3):876-9. (09/2010)
  • S. Kalghati, G Fridman, G Nagaraj, M Peddinghaus, M Balasubramanian, A Brooks, A Gustole, A Vasiletse, A Fridman, G Friedman. Mechanism of blood coagulation by non-thermal atmospheric pressure dielectric barrier discharge plasma. IEEE transaction on plasma science. Oct 2007, vol 35 issue 5, pages 1559-1566. (10/2007)

Scholarly Journals--Accepted

  • Moyers J, Patel A, Shih W, Nagaraj G. Association of Sociodemographic Factors with Immune Checkpoint Inhibitor Therapy receipt for Metastatic Melanoma. Accepted to JAMAnetworkopen (Accepted). (2020)

Books and Chapters

  • Y.H. Chia, G. Nagaraj, C. Sanchez. Breast Cancer. In A.F. Cashen and B.A. Van Tine, The Washington Manual Hematology and Oncology Subspecialty Consult, 3rd Edition. Lippincott Williams & Wilkins 2012. (2012)
  • G. Nagaraj. Cancer of Unknown Primary. In A.F. Cashen and B.A. Van Tine, The Washington Manual Hematology and Oncology Subspecialty Consult, 3rd Edition. Lippincott Williams & Wilkins 2012. (2012)
  • G. Nagaraj. Introduction to Oncology. In A.F. Cashen and B.A. Van Tine, The Washington Manual Hematology and Oncology Subspecialty Consult, 3rd Edition. Lippincott Williams & Wilkins 2012. (2012)